(Press-News.org) Inappropriate growth and survival signaling, which leads to the aberrant growth of cancer cells, is a driving force behind tumors. Much of current cancer research focuses on the kinase enzymes whose mutations are responsible for such disregulated signaling, and many successful molecularly targeted anti-cancer therapeutics are directed at inhibiting kinase activity.
Now, UCLA researchers from the Crump Institute for Molecular Imaging, the Institute for Molecular Medicine, the California NanoSystems Institute, the Jonsson Comprehensive Cancer Center and the department of molecular and medical pharmacology have developed an in vitro method for assessing kinase activity in minute tissue samples from patients. The method involves an integrated microfluidics and imaging platform that can reproducibly measure kinase enzymatic activity from as few as 3,000 cells.
In a paper published Nov. 1 in the journal Cancer Research, the UCLA researchers describe several new technological advances in microfluidics and imaging detection they co-developed to measure kinase activity in small-input samples. The team applied their microfluidic kinase assay to human leukemia patient samples.
"Because the device requires only a very small tissue sample to give results, this method creates new potential for direct kinase experimentation and diagnostics on patient blood, bone marrow and needle biopsy samples," said lead investigator Thomas Graeber, a UCLA professor of molecular and medical pharmacology. "For example, the stem cell properties of leukemia can be directly studied from patient samples."
To improve radio-signal detection, the team used a novel imaging detector, in the form of a solid-state beta camera, which can sensitively detect and spatially resolve radioactive signal directly from a microfluidic chip. The beta camera provides a picture of the activity on the chip, allowing real-time monitoring of the assay performance and outcome. It is highly sensitive and quantitative.
In their first application of the device, the team measured the activity of the mutated kinase responsible for chronic myelogenous leukemia. This mutation is targeted by the clinically successful kinase inhibitor Gleevec.
"We are not aware of other work demonstrating solid-state integrated radioactive imaging from a microfluidic platform," said co-investigator Arion Chatziioannou, a UCLA professor of molecular and medical pharmacology.
The resulting microfluidic in vitro kinase radioassay improves reaction efficiency, compared with standard assays, and can be processed in much less time. This greater efficiency, coupled with the high sensitivity of the beta camera, reduces the amount of sample cell input by two to three orders of magnitude, compared with conventional and 96-well assays. The assay includes a kinase immunocapture step to increase specificity towards the kinase of interest.
"To get the kinase assay to work in a microfluidic environment, we needed to develop new protocols and reagents for efficiently manipulating solid-support kinase capture beads using microfluidic trap-and-release valves," said co-investigator Hsian-Rong Tseng , a UCLA professor of molecular and medical pharmacology.
"Integration of the solid-state beta camera allows researchers to monitor the assay in real time, which proved useful during our protocol development and testing," said Cong Fang, the leading graduate student on the project. "The integrated microfluidic and imaging platform opens new possibilities and makes miniaturization of many common radioactivity-based bioassays to the microfluidic realm possible."
"With the integration of the compact camera, the microfluidic format assay has the potential to be developed into inexpensive bench-top, stand-alone units," said UCLA postdoctoral fellow Nam Vu, who led the imaging development.
"Taken together, the reduced sample input required, the decreased assay time, and the digitally controlled reproducibility of the team's microfluidic kinase radioassay facilitates direct experimentation on clinical samples that are either precious or perishable," said UCLA postdoctoral fellow Yanju Wang, who led the design of the network of microfluidic components that run the assay.
Future experiments will develop reproducible sample collection and measurement conditions for primary patient samples.
Other applications could include profiling of patient and animal model samples for their kinase-inhibitor drug sensitivity, or measurement of kinase activity from stem cells, cancer stem cells and other rare immune cells.
###
The research team included collaborators from Children's Hospital Los Angeles' division of hematology and oncology and the University of Southern California.
The California NanoSystems Institute at UCLA is an integrated research facility located at UCLA and UC Santa Barbara. Its mission is to foster interdisciplinary collaborations in nanoscience and nanotechnology; to train a new generation of scientists, educators and technology leaders; to generate partnerships with industry; and to contribute to the economic development and the social well-being of California, the United States and the world. The CNSI was established in 2000 with $100 million from the state of California. An additional $850 million of support has come from federal research grants and industry funding. CNSI members are drawn from UCLA's College of Letters and Science, the David Geffen School of Medicine, the School of Dentistry, the School of Public Health and the Henry Samueli School of Engineering and Applied Science. They are engaged in measuring, modifying and manipulating atoms and molecules — the building blocks of our world. Their work is carried out in an integrated laboratory environment. This dynamic research setting has enhanced understanding of phenomena at the nanoscale and promises to produce important discoveries in health, energy, the environment and information technology.
For more news, visit the UCLA Newsroom and follow us on Twitter.
END
COLUMBUS, Ohio – New research suggests that the addition of ultraviolet light to the brushing and suction of a vacuum cleaner can almost double the removal of potentially infectious microorganisms from a carpet's surface when compared to vacuuming alone.
Researchers say the findings suggest that incorporating the germicidal properties of UV light into vacuuming might have promise in reducing allergens and pathogens from carpets, as well.
"What this tells us is there is a commercial vacuum with UV technology that's effective at reducing surface microbes. This has promise ...
BUFFALO, N.Y. -- Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.
A paper appearing online in Nanomedicine: Nanotechnology, Biology and Medicine as an article-in-press describes specific delivery of a chemotherapeutic drug to specific cells in the lung, particularly the alveolar white cell, without causing acute inflammation.
Quantum dots are tiny semiconductor particles generally no larger ...
Washington, November 1, 2010 – Elderly women are at high risk for inappropriate urinary catheter utilization in emergency departments, according to a new study in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
The study was conducted at St John Hospital and Medical Center, a 769-bed tertiary care teaching hospital in Detroit, Mich. The authors examined 532 instances in which urinary catheters were placed in emergency room patients over a 12-week ...
Along with energy conservation and storm-water reduction, scientists may soon be adding crime-fighting to the list of benefits that urban trees provide. Researchers with the U.S. Forest Service's Pacific Northwest (PNW) and Southern Research Stations have published a new study that suggests that certain types of city trees may help lower property and violent crime rates. Their study—which is posted online in advance of its appearance in a forthcoming printed issue of the journal Environment and Behavior—is the first to examine the effects of trees and other factors on crime ...
COLUMBIA, Mo. – It may seem difficult to change stereotypical thinking. Perceptions can be very important in forming an individual's attitudes. Now, researchers at the University of Missouri have found that people conditioned to think in opposition to racial stereotypes are more receptive to people from minority groups starring in commercial advertising.
Saleem Alhabash, a doctoral candidate in the University of Missouri School of Journalism.
"This research shows that when people are trained to think in a non-stereotypical way, they will pay more attention to ads with ...
GMOs, or Genetically Modified Organisms, may raise concerns of genes escaping from crops and having unknown effects on natural, wild species. But what is the real risk that traits associated with GMOs will actually migrate to and persist in their wild relatives? Interest in plant ecology, crop production and weed management led John Lindquist and his colleagues from the University of Nebraska and USDA-ARS to investigate how gene flow from a cultivated crop to a weedy relative would influence the ecological fitness of a cropwild hybrid offspring. They published their findings ...
WASHINGTON —People aren't very accurate at predicting how good or bad they'll feel after an event -- such as watching their team lose the big game or getting a flat-screen TV. But afterwards, they "misremember" what they predicted, revising their prognostications after the fact to match how they actually feel, according to new research.
These findings appear in the November issue of the Journal of Experimental Psychology: General, published by the American Psychological Association.
Although the process of predicting emotions seems imprecise from start to finish, misremembering ...
To a hungry fish on the prowl, the split-second neural processing required to see, track, and gobble up a darting flash of prey is a matter of survival.
To scientists, it's a window into how our brain coordinates the eye motions that enable us to hit a baseball, sidestep an errant skateboarder, and otherwise make our way in a world full of danger and opportunity.
This process is now better understood, thanks to a team of scientists that imaged the activity of individual neurons in a part of a zebrafish's brain called the optic tectum. The optic tectum receives signals ...
When Stephen Barrager was diagnosed in 2007 with acute multiple myeloma, a form of bone marrow cancer, he endured the same anxiety that troubles all those who receive an upsetting diagnosis. The way he went about dealing with his disease and its treatment, however, was different. Barrager drew upon his engineering and management science background to help him make difficult decisions. Now he is sharing his insights with hospitals and doctors in his native Bay Area and with colleagues at a conference coming to Austin on Nov. 7, 2010.
The annual meeting of the Institute ...
Orange, Calif., Nov 1, 2010 — A UC Irvine oncologist's work with a targeted therapy is showing great promise in patients with a deadly form of lung cancer. The results were published Thursday in the New England Journal of Medicine.
The multicenter study is testing whether the drug crizotinib effectively slows, stops or reverses growth in advanced non-small cell lung cancer tumors by targeting a genetic mutation that causes uncontrolled tumor growth. Study participants all tested positive for a mutation in the anaplastic lymphoma kinase gene.
According to the findings, ...
